Zevra Therapeutics Ownership | Who Owns Zevra Therapeutics?
Zevra Therapeutics Ownership Summary
Zevra Therapeutics is owned by 20.46% institutional investors, 1.40% insiders, and 78.14% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.06% of ZVRA shares. Fidelity Contrafund is the top mutual fund, with 3.17% of its assets in Zevra Therapeutics shares.
ZVRA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Zevra Therapeutics | 20.46% | 1.40% | 78.14% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 4.46M | 8.06% | $41.53M |
| Woodline partners lp | 3.45M | 6.24% | $32.16M |
| Vanguard group | 3.31M | 5.91% | $29.61M |
| Fmr | 3.21M | 5.81% | $29.93M |
| Nantahala capital management | 2.52M | 4.56% | $23.50M |
| Altium capital management lp | 1.85M | 3.87% | $15.43M |
| State street | 1.56M | 2.82% | $14.55M |
| Geode capital management | 1.37M | 2.48% | $12.79M |
| Aigh capital management | 1.20M | 2.17% | $11.18M |
| Morgan stanley | 1.19M | 2.16% | $11.11M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Altium capital management lp | 1.85M | 4.38% | $15.43M |
| Retirement planning co of new england | 651.15K | 2.47% | $6.07M |
| Stonepine capital management | 480.00K | 1.79% | $4.47M |
| Propel bio management | 282.42K | 1.66% | $2.64M |
| Aigh capital management | 1.20M | 1.53% | $11.18M |
| Nantahala capital management | 2.52M | 0.87% | $23.50M |
| Kingdon capital management | 775.00K | 0.79% | $7.22M |
| Mystic asset management | 361.28K | 0.78% | $3.37M |
| 683 capital management | 975.00K | 0.47% | $9.09M |
| Pharvision advisers | 66.73K | 0.36% | $634.63K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Aigh capital management | 1.20M | 1.53% | 1.20M |
| Point72 asset management | 1.16M | 0.01% | 1.16M |
| Fmr | 3.21M | 0.00% | 818.38K |
| Nantahala capital management | 2.52M | 0.87% | 750.00K |
| Qube research | 842.32K | 0.01% | 486.08K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rubric capital management lp | - | - | -1.96M |
| Velan capital investment management lp | - | - | -715.00K |
| Millennium management | 590.27K | 0.00% | -544.09K |
| Vestal point capital, lp | - | - | -525.00K |
| Silverarc capital management | - | - | -350.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Point72 asset management | 1.16M | 0.01% | 1.16M | $10.78M |
| Algert global | 418.55K | 0.07% | 418.55K | $3.98M |
| Vanguard fiduciary trust | 395.88K | 0.00% | 395.88K | $3.69M |
| Flputnam investment management | 350.50K | 0.05% | 350.50K | $3.27M |
| Phocas financial | 159.42K | 0.23% | 159.42K | $1.49M |
Sold Out
| Holder | Change |
|---|---|
| Thompson investment management | -1.00 |
| Clearstead advisors | -1.00 |
| Sjs investment consulting | -3.00 |
| Ifp advisors | -4.00 |
| Capital performance advisors llp | -40.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 70 | -58.33% | 11,315,248 | -70.34% | 20 | 0.44% | 36 | -56.63% | 20 | -60.00% |
| Dec 31, 2025 | 114 | -35.96% | 23,766,788 | -40.43% | 42 | 0.80% | 57 | -46.73% | 30 | -21.05% |
| Sep 30, 2025 | 169 | 42.02% | 39,764,013 | 12.97% | 72 | 1.76% | 101 | 55.38% | 37 | 37.04% |
| Jun 30, 2025 | 125 | 6.84% | 36,154,652 | 1.99% | 65 | 1.54% | 68 | 15.25% | 28 | -3.45% |
| Mar 31, 2025 | 116 | 2.65% | 35,432,635 | 4.54% | 65 | 1.30% | 58 | -13.43% | 29 | 70.59% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Contrafund | 1.87M | 3.17% | 87.36K |
| Vanguard Total Stock Mkt Idx Inv | 1.77M | 2.99% | - |
| iShares Russell 2000 ETF | 1.32M | 2.24% | 11.14K |
| Fidelity Contrafund Commingled Pl Cl S | 749.62K | 1.27% | 57.37K |
| Vanguard Institutional Extnd Mkt Idx Tr | 643.85K | 1.09% | 3.51K |
| Fidelity Small Cap Index | 544.98K | 0.92% | 4.02K |
| International Biotechnology Ord | 506.03K | 0.86% | - |
| iShares Russell 2000 Growth ETF | 455.52K | 0.77% | 1.17K |
| iShares Biotechnology ETF | 407.72K | 0.69% | 2.58K |
| Fidelity Contrafund K6 | 402.91K | 0.68% | 13.17K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 11, 2026 | Thompson Rahsaan | Chief Legal & Compliance | Sell | $20.27K |
| Feb 09, 2026 | McFarlane Neil F. | President and CEO | Sell | $125.19K |
| Feb 03, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Sell | $27.55K |
| Feb 03, 2026 | Schafer Joshua | CCO | Sell | $96.50K |
| Jan 30, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Sell | $15.44K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 1 |
| 2026 Q1 | - | 8 |
| 2025 Q4 | - | 1 |
| 2025 Q3 | 3 | - |
| 2025 Q2 | - | 1 |
ZVRA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools